MedTrace Logo

Selenious Yeast in CLL Patients w/o Indication of Chemotherapy

NCT05136378 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-11-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of Selenious Yeast Tablets in Chronic Lymphocytic Leukemia Patients without Indication of Chemotherapy

Conditions

  • Chronic Lymphocytic Leukemia Stage A(0)
  • Chronic Lymphocytic Leukemia Stage A(I)
  • Chronic Lymphocytic Leukemia Stage A(II)
  • Chronic Lymphocytic Leukaemia Stage B(I)

Interventions

DRUG

Low Dose Selenious Yeast Tablets

Low dose of Selenious Yeast Tablets

DRUG

High Dose Selenious Yeast Tablets

High Dose Selenious Yeast Tablets

Sponsors & Collaborators

  • Shanghai Changzheng Hospital

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05136378 on ClinicalTrials.gov